logo
Layla Kapok Pillow review 2025: Customized support for an uninterrupted night's rest

Layla Kapok Pillow review 2025: Customized support for an uninterrupted night's rest

Tom's Guide5 days ago

Layla is a brand familiar to many Americans, thanks to its wide range of memory foam mattresses crafted to provide premium comfort and support without a hefty price tag.
The Layla Kapok is one of the brand's top-selling products, created to be the "one pillow to rule them all" with a fully adjustable memory foam and kapok fiber fill. What makes it stand out from the best pillows we have reviewed is the addition of naturally hypoallergenic and breathable kapok fibers, which are silkier and softer than organic cotton.
Here we take a close look at the Layla Kapok pillow, assessing it against core performance indicators such as comfort, support and temperature regulation. If you're short on time, scroll down to find a brief summary:
Type: Shredded memory foam and kapok fibersBest for: All sleepersSizes: Queen, kingTrial: 30 nightsWarranty: 5 yearsPrice: From $109 MSRP at Layla
As already mentioned, the Layla Kapok pillow is designed to suit all sleeping styles and body types. It comes overstuffed with its foam and kapok fiber fill, which you can remove (and store in the complimentary bag that comes with it) to create the ideal feel, comfort and pillow loft your sleeping position requires.
It provides a contouring yet firm support for all sleeping styles, especially for those who sleep on their side. Our lead tester, a combination sleeper (side and back), was impressed by how it perfectly meets her sleep preferences in terms of the loft, support and comfort, which eases the pressure on the neck muscles.
We tested the Layla Kapok Pillow during a particularly warm summer with the temperature going up to 27°C (68°F) and found it to sleep neutral. Hot sleepers might, therefore, require a pillow with specialized cooling tech to combat the heat and night sweats. Additionally, we also think the hypoallergenic kapok fill will be a good fit for sleepers who are prone to allergies.
The Layla Kapok Pillow starts from $109 for a queen size. Let's now look at the pillow specs and performance in detail:
Layla is mainly focused on creating affordable mattresses that offer great comfort and support for the money you pay. While adjustable pillows are made to fit everyone and therefore pricier than the traditional models, the Layla Kapok is definitely more expensive than other brands we've seen.
The Kapok model is the most expensive out of the two pillow options offered by the brand, with the queen priced at $109 and the king at $129. However, Layla is also known for its frequent mattress sales, which also mean good discounts on its pillows. The current 'buy one get one 50% off' bundle sale is a great example, dropping the cost of a pair of queen pillows from $218 to $163.50.
In terms of benefits, Layla is almost as good as Coop Sleep Goods (which has the top bedding benefits we've seen so far), with a 30-night trial, 5-year warranty and free shipping and returns.
Layla Kapok Pillow: from $109 at LaylaThe Layla Kapok Pillow is available in two sizes: queen and king. The MSRP for a queen is $109 while a king is priced at $129. This also includes a 30-night trial, 5-year warranty and free shipping and returns.
The Layla Kapok has a fully adjustable fill made of CERTIPUR-US certified shredded memory foam and kapok fibers, resulting in a medium-firm to firm pillow suitable for all sleeping positions and body types.
The biggest highlight of the design is the striking grey and white honey-combed OEKO-TEX certified fabric cover, made from 68% polyester, 33% rayon and 1% spandex.
The slightly raised hexagonal texture is soft to the touch and comforting enough to enable you to relax. Unlike other options with gussets, piping or frills, the Layla Kapok pillow features a thin seam, adding to its fuss-free construction.
The composition is vegan, hypoallergenic and naturally moisture wicking, and resistant from dust mites and other allergens. Kapok fibers are also silkier to touch and softer than cotton, so you get a breathable and contouring blend when incorporated with memory foam.
We slept on the Layla Kapok pillow for two weeks testing the core parameters which makes up a good headrest. These are our findings below:
Like most adjustable models, the Layla Kapok arrived in a cardboard box, rolled up and sealed in a plastic cover, and came with a cloth bag for storing any fill you remove while customizing it to suit your preferences.
The fully-stuffed pillow began to unfurl and expand as soon as it was out of the package. Although there weren't any specific instructions from the brand regarding the expansion time, our tester waited for 24 hours before sleeping on it.
Like the best memory foam mattresses, you might also notice some off-gassing in foam-blend pillows too. However, in our experience the Layla Kapok did not have any noticeable smell during the expansion period.
Nailing the right amount of fill was one thing I struggled with initially, since I prefer a plush feel to my pillows. It took a while for me to break into the pillow and get adjusted to the medium-firmness it offered.
Score: 4.5 out of 5
Being a combination sleeper (side and back), I found the Layla Kapok to be a bit too firm to break into. I then removed about a quarter of the foam and kapok fiber fill, and fluffed it up to evenly distribute the fill and bring it back to its original shape.
The pillow felt perfect for both the positions and especially for side sleeping. After the slight readjustment, it seemed to provide the right loft and support, to bridge the gap between the ears and shoulders, while lying on the side.
Since there weren't any clear guidelines on setting up the pillow for each position, we reached out to Layla directly. We learned that while side and back sleepers may need to remove only a little (amount not mentioned), stomach sleepers might have to remove much more to flatten it out and ensure it does not compromise a healthy spinal alignment.
In comparison with the Coop Original Adjustable pillow I reviewed previously, the Layla Kapok is by no means a plush pillow. This could be because of the difference in the type of fiber used.
While this might be considered a major drawback, especially for those who prefer a softer and fluffier pillow, it is also one of the advantages the Layla has over the Coop Adjustable, since the latter tends to flatten or shift easily.
As an objective test to gauge its comfort and support, I placed a 10lb (roughly equivalent to an adult head) kettlebell on the center of the pillow. After waiting for five minutes, I removed the weight.
The pillow took over seven seconds to return to its original shape and firmness. This is line with our experience of sleeping on the Layla Kapok, which overall maintained its support and shape consistently, and required only minimal fluffing up during the testing period.
Score: 4 out of 5
Most memory foam pillows are known to retain heat, unless they also feature organic cooling materials or specialized tech.
The Layla Kapok is made with a combination of memory foam and breathable and naturally moisture-wicking kapok fibers, but lacks other dedicated cooling tech to beat the heat.
I tested the Layla Kapok Pillow when the temperatures were soaring high up to 27°C (68°F). Even with the Sijo Airyweight Cooling mattress protector, I did wake up one morning feeling hot and stuffy, due to the sunrise-facing position of my bedroom.
Conclusion? The Layla Kapok basically sleeps at a neutral temperature and will not cater to extremely hot sleepers or warm weather.
Score: 3.5 out of 5
While we should remind you that your pillows need to replaced every one to two years, it's important that the one you sleep on every night is built to last. Let's now look into whether the Layla Kapok passed this test.
While the two-week testing period is insufficient to understand whether it will stand the test of time, based on the construction and use of premium materials, we think the Layla Kapok pillow is made to last.
Our tester also didn't notice any sagging or flattening, which is a common failing in other memory foam-blend pillows. It proved to maintain its support, comfort and shape overall, without the need for frequent fluffing or readjustments.
Score: 5 out of 5
The outer polyester cover of the Layla Kapok pillow is machine-washable. Pop it in a cold water cycle and tumble dry on low heat. The inner fill layer, however, is spot clean only.
While you can fluff it up by hand, the brand also recommends putting it in the dryer for five to 10 minutes on the lowest heat setting, every so often.
Score: 4 out of 5
During our two-week testing period, our combination sleeping tester was convinced that the Layla Kapok Pillow is best suited to side and back sleeping.
The fully adjustable foam and kapok fiber fill will be a perfect fit for anyone who prefers a firm pillow that supports their head, neck and shoulders. Unlike the Coop Original Adjustable, this does not flatten or shift easily during the night and requires minimal fluffing to maintain its shape and support.
However, we recommend that stomach sleepers opt for a softer model such as the Tempur-Cloud, which is designed for that specific position and hence comes ready to be slept on.
Our reviewer also thought that the Layla Kapok slept at a neutral temperature throughout the testing period. Hot sleepers, therefore, might need something designed specifically for cooling, like the Casper Hybrid with Snow Technology, as the breathability of the kapok fiber would prove to be insufficient in handling extreme heat or night sweats.
Overall, we think the Layla Kapok is a strong choice for sleepers in search of a low-maintenance and consistently supportive adjustable pillow that offers generous sleep benefits for its price.
✅ You're a side sleeper: You'll need little to no adjustment, since the Layla Kapok perfectly bridges the gap between your ears and shoulders while lying on the side.
✅ You prefer a medium-firm supportive pillow: Unlike other plush adjustable options that tend to flatten easily, the Layla Kapok maintains its shape and medium-firm support for longer.
✅ You want extra benefits: The Layla Kapok pillow comes with a 30-night sleep trial and 5-year warranty, so you can try it stress-free before committing.
❌ You like a plush pillow: The Layla Kapok remains medium-firm no matter how much fill you remove, so if you prefer a plush pillow, this might not be right for you.
❌ You're a stomach sleeper: You'll have to remove a good quantity of the fill to achieve the loft and comfort that's ideal for stomach sleeping. It's easier to opt for dedicated models like the Tempur-Cloud instead.
❌ You're a hot sleeper: Made from a memory foam and kapok fiber fill, you'll not find it to be the most cooling option, especially if you're prone to overheating or night sweats.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

As new variant spreads, what's the latest COVID-19 vaccine guidance? It's complicated.
As new variant spreads, what's the latest COVID-19 vaccine guidance? It's complicated.

USA Today

time26 minutes ago

  • USA Today

As new variant spreads, what's the latest COVID-19 vaccine guidance? It's complicated.

As a new COVID-19 variant takes over in the U.S., guidance surrounding vaccines has become increasingly confusing. Changes in vaccination guidelines, ever-evolving variants and strains, along with threats to health insurance, have sent average Americans looking for the latest recommendations as members of the federal government often conflict with independent medical agencies and healthcare professionals. In the two weeks leading up to June 21, the Centers for Disease Control and Prevention (CDC) reported just shy of 14,500 positive COVID tests, and while hospitalizations and deaths are fortunately down significantly since the pandemic's peak, vulnerable people are still grappling with limiting their risk amid changing practices. Having trouble keeping track of variants and vaccines? Here's what we know. What is the new NB.1.8.1 COVID variant? NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May. Verma previously stated that NB.1.8.1 may be transferred more easily than LP.8.1. Additionally, he noted that NB.1.8.1 can evade antibodies created by vaccines or past infections more easily than LP.8.1. In early April, NB.1.8.1 accounted for 0% of COVID cases in the U.S. In the two weeks ending June 21, it accounted for the majority of cases at 43%, according to the CDC. The variant has similar symptoms to other strains, including fever or chills, cough, shortness of breath or difficulty breathing, sore throat, congestion or a runny nose, new loss of taste or smell, fatigue, muscle or body aches, headache, nausea or vomiting. One of its more unique features is "razor blade throat," reported by patients as an exceptionally sore throat. RFK and HHS change COVID vaccine guidance Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process. Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection. The American College of Obstetricians and Gynecologists (ACOG) and American Academy of Pediatrics (AAP), among other organizations, issued statements condemning the change, with the ACOG saying it was "...concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy." "It is very clear that COVID-19 infection during pregnancy can be catastrophic and lead to major disability, and it can cause devastating consequences for families. The COVID-19 vaccine is safe during pregnancy, and vaccination can protect our patients and their infants after birth," President Steven J. Fleischman said in a statement. Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay out of pocket to get the shot, which runs about $200, if they can get it. It's not clear what insurance companies will do about the new recommendations. AMA, AAP other organizations break from RFK and HHS on vaccines The American Medical Association (AMA) and American Academy of Pediatrics (AAP), in partnership with other professional medical organizations, broke from RFK and HHS after this announcement, sharing plans to develop their own guidelines independent of the government organization. In an open letter signed by 80 medical organizations across the country and published on June 25, the AMA called for physicians, healthcare networks and insurance companies to continue supporting "evidence-based immunizations to help prevent severe disease and protect public health." "Vaccines for influenza, RSV, and COVID-19 remain among the best tools to protect the public against these illnesses and their potentially serious complications—and physicians are among the most trusted voices to recommend them. We come together as physicians from every corner of medicine to reaffirm our commitment to these lifesaving vaccines," the letter said. "Recent changes to federal immunization review processes raised concerns across the medical and public health community. In this moment of uncertainty, physicians must align around clear, evidence-based guidance for patients." The AAP likewise said in a June 26 statement that it will "continue to publish its own evidence-based recommendations and schedules." AAP President Susan J. Kressly said the creation of federal immunization policy is 'no longer a credible process," adding, "...we're not stepping back, we're stepping up. The AAP will continue to publish our own immunization schedule just as we always have, developed by experts, guided by science, trusted by pediatricians and families across the country.' These latest independent guidelines have yet to be released. Vaccine committee adjourns without fresh recommendations Meanwhile, the new Advisory Committee on Immunization Practices (ACIP) gathered for the first time on June 25 in a meeting that drew criticism from some experts. RFK fired all 17 original members of the committee on June 9, replacing them with members that critics have called unqualified. Some of the members, like Kennedy, have a history of anti-vaccine advocacy, prompting backlash that had doctors and organizations calling for a delay in the meeting. Anti-vaccine sentiments were repeated by ACIP Chair Martin Kulldorf at the meeting, who said the panel will be "investigating" MMR and childhood vaccines. The CDC panel also reviewed data about COVID-19 vaccines, questioning their safety and effectiveness. They also raised questions about the study design, methodologies and surveillance monitoring systems behind the data, which Dr. Pamela Rockwell, clinical professor of family medicine at the University of Michigan Medical School, addressed as a standard of medical research. "Our efforts, through a very robust system of checks and balances, are to create vaccines and vaccination programs that result in the most benefit with the least harm," said Dr. Gretchen LaSalle, a family physician in Spokane, Washington, who represented the American Academy of Family Physicians. Despite this, the committee didn't vote on COVID-19 vaccine recommendations for the fall and isn't expected to reconvene until 'September/October,' according to the CDC website. ACIP commitee: Inside the unusual, RFK-appointed panel that's deciding on childhood vaccines FDA updates warning label for COVID vaccines The FDA likewise announced updated requirements for mRNA COVID-19 vaccine warning labels on June 25, which apply to Comirnaty by Pfizer Inc. and Spikevax by ModernaTX Inc. Prescribing information will now include warnings of the connection between the vaccines and a rare side effect that causes inflammation of the heart muscle and lining. The new warning label discloses the risk of myocarditis, which appeared in 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old, mostly commonly among males aged 12 to 24. The previous label, which also disclosed the risk, said the problem mostly occurred in minors aged 12-17. So, how do you protect yourself from NB.1.8.1 and other variants? Despite the back-and-forth in the U.S., the World Health Organization (WHO) has kept its recommendation consistent. Currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant, it said. In a webpage dated Jan. 7, the CDC advised that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine. The page has since been updated with a banner, reading "COVID-19 vaccine recommendations have recently been updated for some populations. This page will be updated to align with the updated immunization schedule." The original recommendations align with the WHO's current guidelines. WHO, AMA, AAP and existing standards recommend that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially. Contributing: Greta Cross, Adrianna Rodriguez, USA TODAY

Many forget the damage done by diseases like whooping cough, measles and rubella. Not these families

time11 hours ago

Many forget the damage done by diseases like whooping cough, measles and rubella. Not these families

SIOUX FALLS, S.D. -- In the time before widespread vaccination, death often came early. Devastating infectious diseases ran rampant in America, killing millions of children and leaving others with lifelong health problems. These illnesses were the main reason why nearly one in five children in 1900 never made it to their fifth birthday. Over the next century, vaccines virtually wiped out long-feared scourges like polio and measles and drastically reduced the toll of many others. Today, however, some preventable, contagious diseases are making a comeback as vaccine hesitancy pushes immunization rates down. And well-established vaccines are facing suspicion even from public officials, with Robert F. Kennedy Jr., a longtime anti-vaccine activist, running the federal health department. 'This concern, this hesitancy, these questions about vaccines are a consequence of the great success of the vaccines – because they eliminated the diseases,' said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center. 'If you're not familiar with the disease, you don't respect or even fear it. And therefore you don't value the vaccine.' Anti-vaccine activists even portray the shots as a threat, focusing on the rare risk of side effects while ignoring the far larger risks posed by the diseases themselves — and years of real-world data that experts say proves the vaccines are safe. Some Americans know the reality of these preventable diseases all too well. For them, news of measles outbreaks and rising whooping cough cases brings back terrible memories of lives forever changed – and a longing to spare others from similar pain. With a mother's practiced, guiding hand, 80-year-old Janith Farnham helped steer her 60-year-old daughter's walker through a Sioux Falls art center. They stopped at a painting of a cow wearing a hat. Janith pointed to the hat, then to her daughter Jacque's Minnesota Twins cap. Jacque did the same. 'That's so funny!' Janith said, leaning in close to say the words in sign language too. Jacque was born with congenital rubella syndrome, which can cause a host of issues including hearing impairment, eye problems, heart defects and intellectual disabilities. There was no vaccine against rubella back then, and Janith contracted the viral illness very early in the pregnancy, when she had up to a 90% chance of giving birth to a baby with the syndrome. Janith recalled knowing 'things weren't right' almost immediately. The baby wouldn't respond to sounds or look at anything but lights. She didn't like to be held close. Her tiny heart sounded like it purred – evidence of a problem that required surgery at four months old. Janith did all she could to help Jacque thrive, sending her to the Colorado School for the Deaf and the Blind and using skills she honed as a special education teacher. She and other parents of children with the syndrome shared insights in a support group. Meanwhile, the condition kept taking its toll. As a young adult, Jacque developed diabetes, glaucoma and autistic behaviors. Eventually, arthritis set in. Today, Jacque lives in an adult residential home a short drive from Janith's place. Above her bed is a net overflowing with stuffed animals. On a headboard shelf are photo books Janith created, filled with memories like birthday parties and trips to Mount Rushmore. Jacque's days typically begin with an insulin shot and breakfast before she heads off to a day program. She gets together with her mom four or five days a week. They often hang out at Janith's townhome, where Jacque has another bedroom decorated with her own artwork and quilts Janith sewed for her. Jacque loves playing with Janith's dog, watching sports on television and looking up things on her iPad. Janith marvels at Jacque's sense of humor, gratefulness, curiosity and affectionate nature despite all she's endured. Jacque is generous with kisses and often signs 'double I love yous' to family, friends and new people she meets. 'When you live through so much pain and so much difficulty and so much challenge, sometimes I think: Well, she doesn't know any different,' Janith said. Given what her family has been through, Janith believes younger people are being selfish if they choose not to get their children the MMR shot against measles, mumps and rubella. 'It's more than frustrating. I mean, I get angry inside,' she said. 'I know what can happen, and I just don't want anybody else to go through this.' More than half a century has passed, but Patricia Tobin still vividly recalls getting home from work, opening the car door and hearing her mother scream. Inside the house, her little sister Karen lay unconscious on the bathroom floor. It was 1970, and Karen was 6. She'd contracted measles shortly after Easter. While an early vaccine was available, it wasn't required for school in Miami where they lived. Karen's doctor discussed immunizing the first grader, but their mother didn't share his sense of urgency. 'It's not that she was against it," Tobin said. "She just thought there was time.' Then came a measles outbreak. Karen – who Tobin described as a 'very endearing, sweet child' who would walk around the house singing – quickly became very sick. The afternoon she collapsed in the bathroom, Tobin, then 19, called the ambulance. Karen never regained consciousness. 'She immediately went into a coma and she died of encephalitis,' said Tobin, who stayed at her bedside in the hospital. 'We never did get to speak to her again.' Today, all states require that children get certain vaccines to attend school. But a growing number of people are making use of exemptions allowed for medical, religious or philosophical reasons. Vanderbilt's Schaffner said fading memories of measles outbreaks were exacerbated by a fraudulent, retracted study claiming a link between the MMR shot and autism. The result? Most states are below the 95% vaccination threshold for kindergartners — the level needed to protect communities against measles outbreaks. 'I'm very upset by how cavalier people are being about the measles,' Tobin said. 'I don't think that they realize how destructive this is.' One of Lora Duguay's earliest memories is lying in a hospital isolation ward with her feverish, paralyzed body packed in ice. She was three years old. 'I could only see my parents through a glass window. They were crying and I was screaming my head off,' said Duguay, 68. 'They told my parents I would never walk or move again.' It was 1959 and Duguay, of Clearwater, Florida, had polio. It mostly preyed on children and was one of the most feared diseases in the U.S., experts say, causing some terrified parents to keep children inside and avoid crowds during epidemics. Given polio's visibility, the vaccine against it was widely and enthusiastically welcomed. But the early vaccine that Duguay got was only about 80% to 90% effective. Not enough people were vaccinated or protected yet to stop the virus from spreading. Duguay initially defied her doctors. After intensive treatment and physical therapy, she walked and even ran – albeit with a limp. She got married, raised a son and worked as a medical transcriptionist. But in her early 40s, she noticed she couldn't walk as far as she used to. A doctor confirmed she was in the early stages of post-polio syndrome, a neuromuscular disorder that worsens over time. One morning, she tried to stand up and couldn't move her left leg. After two weeks in a rehab facility, she started painting to stay busy. Eventually, she joined arts organizations and began showing and selling her work. Art "gives me a sense of purpose,' she said. These days, she can't hold up her arms long enough to create big oil paintings at an easel. So she pulls her wheelchair up to an electric desk to paint on smaller surfaces like stones and petrified wood. The disease that changed her life twice is no longer a problem in the U.S. So many children get the vaccine — which is far more effective than earlier versions — that it doesn't just protect individuals but it prevents occasional cases that arrive in the U.S. from spreading further. ' Herd immunity" keeps everyone safe by preventing outbreaks that can sicken the vulnerable. Every night, Katie Van Tornhout rubs a plaster cast of a tiny foot, a vestige of the daughter she lost to whooping cough at just 37 days old. Callie Grace was born on Christmas Eve 2009 after Van Tornhout and her husband tried five years for a baby. She was six weeks early but healthy. 'She loved to have her feet rubbed," said the 40-year-old Lakeville, Indiana mom. "She was this perfect baby.' When Callie turned a month old, she began to cough, prompting a visit to the doctor, who didn't suspect anything serious. By the following night, Callie was doing worse. They went back. In the waiting room, she became blue and limp in Van Tornhout's arms. The medical team whisked her away and beat lightly on her back. She took a deep breath and giggled. Though the giggle was reassuring, the Van Tornhouts went to the ER, where Callie's skin turned blue again. For a while, medical treatment helped. But at one point she started squirming, and medical staff frantically tried to save her. 'Within minutes,' Van Tornhout said, 'she was gone.' Van Tornhout recalled sitting with her husband and their lifeless baby for four hours, "just talking to her, thinking about what could have been.' Callie's viewing was held on her original due date – the same day the Centers for Disease Control and Prevention called to confirm she had pertussis, or whooping cough. She was too young for the Tdap vaccine against it and was exposed to someone who hadn't gotten their booster shot. Today, next to the cast of Callie's foot is an urn with her ashes and a glass curio cabinet filled with mementos like baby shoes. 'My kids to this day will still look up and say, 'Hey Callie, how are you?'' said Van Tornhout, who has four children and a stepson. 'She's part of all of us every day.' Van Tornhout now advocates for childhood immunization through the nonprofit Vaccinate Your Family. She also shares her story with people she meets, like a pregnant customer who came into the restaurant her family ran saying she didn't want to immunize her baby. She later returned with her vaccinated four-month-old. 'It's up to us as adults to protect our children – like, that's what a parent's job is,' Van Tornhout said. 'I watched my daughter die from something that was preventable … You don't want to walk in my shoes.'

Two Days Down The Drain: Americans Spend 49 Hours A Year Using Phones In The Bathroom
Two Days Down The Drain: Americans Spend 49 Hours A Year Using Phones In The Bathroom

Yahoo

time12 hours ago

  • Yahoo

Two Days Down The Drain: Americans Spend 49 Hours A Year Using Phones In The Bathroom

Americans spend an average of 49 hours annually using their phones on the toilet, equivalent to over two full days. A study by QS Supplies, a bathroom supplies company, has prompted doctors to warn of both hygiene and physical health concerns relating to cellphone usage while in the restroom. Gen Z spends 54 hours per year on social media, with 66% scrolling, 40% streaming videos, 37% responding to messages, and 2% taking video calls from the bathroom. Over 61% admitted to lingering on the toilet to finish a task, while 42% use it as a deliberate escape from others, and 51% seek alone time. 'The data shows just how far social media, especially apps like TikTok, have pervaded even our most personal moments,' Farook Member, director of QS Supplies, told the New York Post. Only 25% of people clean their phones after using the bathroom, with Baby Boomers being the least likely to do so. Doctors warn that phones can harbor over 20 times more bacteria than toilet seats, potentially causing colds, flu, and gastrointestinal illnesses. Prolonged sitting, dubbed 'toilet scrolling,' also increases the risk of hemorrhoids—swollen veins in the anus and rectum causing pain, itching, and bleeding—due to extended time on the toilet. Gastroenterologists recommend limiting bathroom phone use to 10-15 minutes and wiping phones daily with disinfectant or alcohol-based solutions to prevent health issues.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store